RZH
Relyea Zuckerberg Hanson Portfolio holdings
AUM
$853M
This Quarter Return
+11.64%
1 Year Return
+18.23%
3 Year Return
+71.51%
5 Year Return
+115.63%
10 Year Return
–
AUM
$513M
AUM Growth
+$513M
(+17%)
Cap. Flow
+$25.8M
Cap. Flow
% of AUM
5.03%
Top 10 Holdings %
Top 10 Hldgs %
54.04%
Holding
240
New
46
Increased
106
Reduced
56
Closed
8
Top Buys
| 1 |
Vanguard Value ETF
VTV
|
$4.75M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$4.34M |
| 3 |
Vanguard Growth ETF
VUG
|
$3.92M |
| 4 |
Procter & Gamble
PG
|
$2.46M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
$2.39M |
Top Sells
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$5.84M |
| 2 |
ARK Innovation ETF
ARKK
|
$1.7M |
| 3 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
$1.37M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$1.29M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
$1.15M |
Sector Composition
| 1 | Technology | 9.22% |
| 2 | Financials | 4.01% |
| 3 | Healthcare | 3.35% |
| 4 | Industrials | 3.03% |
| 5 | Consumer Discretionary | 2.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Qualcomm
QCOM
$169B
| $339K | 0.07% |
+2,343
| New | +$339K |
|
152
Moody's
MCO
$88.7B
| $337K | 0.07% |
863
+148
| +21% | +$57.8K |
|
153
Charles Schwab
SCHW
$174B
| $336K | 0.07% |
4,879
+63
| +1% | +$4.34K |
|
154
Cigna
CI
$79.8B
| $333K | 0.07% |
1,113
+35
| +3% | +$10.5K |
|
155
Danaher
DHR
$144B
| $331K | 0.06% |
1,431
-786
| -35% | -$182K |
|
156
iShares S&P 500 Growth ETF
IVW
$63.1B
| $328K | 0.06% |
4,372
| – | – |
|
157
Novo Nordisk
NVO
$253B
| $327K | 0.06% |
3,159
+99
| +3% | +$10.2K |
|
158
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.2B
| $326K | 0.06% |
1,825
| – | – |
|
159
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.29B
| $324K | 0.06% |
+29,427
| New | +$324K |
|
160
Mondelez International
MDLZ
$78.9B
| $323K | 0.06% |
4,456
+940
| +27% | +$68.1K |
|
161
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$853M
| $322K | 0.06% |
2,992
+95
| +3% | +$10.2K |
|
162
Vanguard Russell 1000 Growth ETF
VONG
$30.9B
| $316K | 0.06% |
4,055
| – | – |
|
163
Progressive
PGR
$144B
| $316K | 0.06% |
+1,986
| New | +$316K |
|
164
AT&T
T
$207B
| $309K | 0.06% |
18,425
+1,626
| +10% | +$27.3K |
|
165
Bristol-Myers Squibb
BMY
$96.8B
| $309K | 0.06% |
6,015
+604
| +11% | +$31K |
|
166
Pfizer
PFE
$141B
| $305K | 0.06% |
10,595
-3,320
| -24% | -$95.6K |
|
167
Verizon
VZ
$183B
| $302K | 0.06% |
8,016
+830
| +12% | +$31.3K |
|
168
Zoetis
ZTS
$67.3B
| $301K | 0.06% |
+1,524
| New | +$301K |
|
169
Lowe's Companies
LOW
$146B
| $295K | 0.06% |
1,323
-219
| -14% | -$48.8K |
|
170
Parker-Hannifin
PH
$94.6B
| $288K | 0.06% |
626
+2
| +0.3% | +$921 |
|
171
Wells Fargo
WFC
$257B
| $277K | 0.05% |
+5,627
| New | +$277K |
|
172
Waste Management
WM
$89.9B
| $277K | 0.05% |
+1,544
| New | +$277K |
|
173
Hartford Financial Services
HIG
$37.3B
| $275K | 0.05% |
3,424
+114
| +3% | +$9.16K |
|
174
Gilead Sciences
GILD
$140B
| $274K | 0.05% |
3,387
+533
| +19% | +$43.2K |
|
175
Colgate-Palmolive
CL
$67.3B
| $273K | 0.05% |
+3,422
| New | +$273K |
|